GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » YoY EPS Growth

Accelerated Pharma (Accelerated Pharma) YoY EPS Growth : 0.00% (As of Mar. 2017)


View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Accelerated Pharma's YoY EPS Growth for the quarter that ended in Mar. 2017 was 0.00%.

Accelerated Pharma's Earnings per Share (Diluted) for the three months ended in Mar. 2017 was $-0.09.


Accelerated Pharma YoY EPS Growth Historical Data

The historical data trend for Accelerated Pharma's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma YoY EPS Growth Chart

Accelerated Pharma Annual Data
Trend Dec14 Dec15 Dec16
YoY EPS Growth
- - 5.94

Accelerated Pharma Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
YoY EPS Growth Get a 7-Day Free Trial - - - 96.51 -

Accelerated Pharma YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Accelerated Pharma's YoY EPS Growth for the fiscal year that ended in Dec. 2016 is calculated as:

YoY EPS Growth (A: Dec. 2016 )
=(Earnings per Share (Diluted) (A: Dec. 2016 )-Earnings per Share (Diluted) (A: Dec. 2015 ))/ | Earnings per Share (Diluted) (A: Dec. 2015 ) |
=(-0.57--0.606)/ | -0.606 |
=5.94 %

Accelerated Pharma's YoY EPS Growth for the quarter that ended in Mar. 2017 is calculated as:

YoY EPS Growth (Q: Mar. 2017 )
=(Earnings per Share (Diluted) (Q: Mar. 2017 )-Earnings per Share (Diluted) (Q: Mar. 2016 )) / | Earnings per Share (Diluted) (Q: Mar. 2016 )) |
=(-0.092-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accelerated Pharma YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Accelerated Pharma (Accelerated Pharma) Business Description

Traded in Other Exchanges
N/A
Address
Website
Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines